The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG
We previously reported interferon gamma secretion by human CD4+ and CD8+ T cells in response to recombinant E. coli-expressed Rv1860 protein of Mycobacterium tuberculosis (MTB) as well as protection of guinea pigs against a challenge with virulent MTB following prime-boost immunization with DNA vaccine and poxvirus expressing Rv1860. In contrast, a Statens Serum Institute Mycobacterium bovis BCG (BCG-SSI) recombinant expressing MTB Rv1860 (BCG-TB1860) showed loss of protective ability compared to the parent BCG strain expressing the control GFP protein (BCG-GFP). Since Rv1860 is a secreted mannosylated protein of MTB and BCG, we investigated the effect of BCG-TB1860 on innate immunity. Relative to BCG-GFP, BCG-TB1860 effected a significant near total reduction both in secretion of cytokines IL-2, IL-12p40, IL-12p70, TNF-α, IL-6 and IL-10, and up regulation of co-stimulatory molecules MHC-II, CD40, CD54, CD80 and CD86 by infected bone marrow derived dendritic cells (BMDC), while leaving secreted levels of TGF-β unchanged. These effects were mimicked by BCG-TB1860His which carried a 6-Histidine tag at the C-terminus of Rv1860, killed sonicated preparations of BCG-TB1860 and purified H37Rv-derived Rv1860 glycoprotein added to BCG-GFP, but not by E. coli-expressed recombinant Rv1860. Most importantly, BMDC exposed to BCG-TB1860 failed to polarize allogeneic as well as syngeneic T cells to secrete IFN-γ and IL-17 relative to BCG-GFP. Splenocytes from mice infected with BCG-SSI showed significantly less proliferation and secretion of IL-2, IFN-γ and IL-17, but secreted higher levels of IL-10 in response to in vitro restimulation with BCG-TB1860 compared to BCG-GFP. Spleens from mice infected with BCG-TB1860 also harboured significantly fewer DC expressing MHC-II, IL-12, IL-2 and TNF-α compared to mice infected with BCG-GFP. Glycoproteins of MTB, through their deleterious effects on DC may thus contribute to suppress the generation of a TH1- and TH17-dominated adaptive immune response that is vital for protection against tuberculosis.
References
[1]
WHO (2012) Global Tuberculosis Report 2012: ix–x. Available: http://www.who.int/tb/publications/globa？l_report/gtbr12_main.pdf. Accessed 13 May 2014.
[2]
Centers for Disease Control (2012) Reported Tuberculosis in the United States 2011. Available: http://www.cdc.gov/tb/statistics/reports？/2011/pdf/report2011.pdf. Accessed 13 May 2014.
[3]
Vergne I, Chua J, Lee H-H, Lucas M, Belisle J, et al. (2005) Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 102: 4033–4038.
[4]
Mariotti S, Teloni R, Iona E, Fattorini L, Giannoni F, et al. (2002) Mycobacterium tuberculosis subverts the differentiation of human monocytes into dendritic cells. European Journal of Immunology 32: 3050–3058.
[5]
Wolf AJ, Linas B, Trevejo-Nu？ez GJ, Kincaid E, Tamura T, et al. (2007) Mycobacterium tuberculosis Infects Dendritic Cells with High Frequency and Impairs Their Function In Vivo. The Journal of Immunology 179: 2509–2519.
[6]
Noss EH, Harding CV, Boom WH (2000) Mycobacterium tuberculosis Inhibits MHC Class II Antigen Processing in Murine Bone Marrow Macrophages. Cellular Immunology 201: 63–74.
[7]
Pancholi P, Mirza A, Bhardwaj N, Steinman RM (1993) Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages. Science 260: 984–986.
[8]
Hickman SP, Chan J, Salgame P (2002) Mycobacterium tuberculosis Induces Differential Cytokine Production from Dendritic Cells and Macrophages with Divergent Effects on Naive T Cell Polarization. The Journal of Immunology 168: 4636–4642.
[9]
Cooper AM (2009) Cell-Mediated Immune Responses in Tuberculosis. Annual Review of Immunology 27: 393–422.
[10]
Torrado E, Cooper AM (2011) What Do We Really Know about How CD4 T Cells Control Mycobacterium tuberculosis? PLoS Pathog 7: e1002196.
[11]
Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, et al. (2000) Immunobiology of Dendritic Cells. Annual Review of Immunology 18: 767–811.
[12]
Szymanski CM, Wren BW (2005) Protein glycosylation in bacterial mucosal pathogens. Nat Rev Micro 3: 225–237.
[13]
Ge Y, ElNaggar M, Sze S, Oh H, Begley T, et al. (2003) Top down characterization of secreted proteins from Mycobacterium tuberculosis by electron capture dissociation mass spectrometry. Journal of the American Society for Mass Spectrometry 14: 253–261.
[14]
González-Zamorano M, Mendoza-Hernández G, Xolalpa W, Parada C, Vallecillo AJ, et al. (2009) Mycobacterium tuberculosis Glycoproteomics Based on ConA-Lectin Affinity Capture of Mannosylated Proteins. Journal of Proteome Research 8: 721–733.
[15]
Dobos KM, Khoo KH, Swiderek KM, Brennan PJ, Belisle JT (1996) Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis. J Bacteriol 178: 2498–2506.
[16]
Horn C, Namane A, Pescher P, Rivière M, Romain Fl, et al. (1999) Decreased Capacity of Recombinant 45/47-kDa Molecules (Apa) of Mycobacterium tuberculosis to Stimulate T Lymphocyte Responses Related to Changes in Their Mannosylation Pattern. Journal of Biological Chemistry 274: 32023–32030.
[17]
Michell SL, Whelan AO, Wheeler PR, Panico M, Easton RL, et al. (2003) The MPB83 Antigen from Mycobacterium bovis ContainsO-Linked Mannose and (1→3)-Mannobiose Moieties. Journal of Biological Chemistry 278: 16423–16432.
[18]
Kang PB, Azad AK, Torrelles JB, Kaufman TM, Beharka A, et al. (2005) The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. The Journal of Experimental Medicine 202: 987–999.
[19]
Geijtenbeek TBH, van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CMJE, et al. (2003) Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function. The Journal of Experimental Medicine 197: 7–17.
[20]
Appelmelk BJ, Den Dunnen J, Driessen NN, Ummels R, Pak M, et al. (2008) The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium–host interaction. Cellular Microbiology 10: 930–944.
[21]
Pitarque S, Herrmann J-L, Duteyrat J-L, Jackson MS, G.R. , Lecointe F, et al. (2005) Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity. Biochem J 392: 615–624.
[22]
Espitia C, Mancilla R (1989) Identification, isolation and partial characterization of Mycobacterium tuberculosis glycoprotein antigens. Clin ExpImmunol 77: 378–383.
[23]
Fifis T, Costopoulos C, Radford AJ, Bacic A, Wood PR (1991) Purification and characterization of major antigens from a Mycobacterium bovis culture filtrate. Infect Immun 59: 800–807.
[24]
Romain F, Augier J, Pescher P, Marchal G (1993) Isolation of a Proline-Rich Mycobacterial Protein Eliciting Delayed-Type Hypersensitivity Reactions Only in Guinea Pigs Immunized with Living Mycobacteria. Proc Natl Acad Sci USA 90: 5322–5326.
[25]
Romain F, Laqueyrerie A, Militzer P, Pescher P, Chavarot P, et al. (1993) Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria. Infect Immun 61: 742–750.
[26]
Espitia C, Espinosa R, Saavedra R, Mancilla R, Romain F, et al. (1995) Antigenic and structural similarities between Mycobacterium tuberculosis 50- to 55-kilodalton and Mycobacterium bovis BCG 45- to 47- kilodalton antigens. Infect Immun 63: 580–584.
[27]
Laqueyrerie A, Militzer P, Romain F, Eiglmeier K, Cole S, et al. (1995) Cloning, sequencing, and expression of the apa gene coding for the Mycobacterium tuberculosis 45/47-kilodalton secreted antigen complex. Infect Immun 63: 4003–4010.
[28]
Romain F, Horn C, Pescher P, Namane A, Riviere M, et al. (1999) Deglycosylation of the 45/47-Kilodalton Antigen Complex of Mycobacterium tuberculosis Decreases Its Capacity To Elicit In Vivo or In Vitro Cellular Immune Responses. Infect Immun 67: 5567–5572.
[29]
Amara RR, Satchidanandam V (1996) Analysis of a genomic DNA expression library of Mycobacterium tuberculosis using tuberculosis patient sera: evidence for modulation of host immune response. Infection and Immunity 64: 3765–3771.
[30]
Amara RR, Satchidanandam V (1997) Differential immunogenicity of novel Mycobacterium tuberculosis antigens derived from live and dead bacilli. Infect Immun 65: 4880–4882.
[31]
Kumar P, Amara RR, Challu VK, Chadda VK, Satchidanandam V (2003) The Apa Protein of Mycobacterium tuberculosis Stimulates Gamma Interferon-Secreting CD4+ and CD8+ T Cells from Purified Protein Derivative-Positive Individuals and Affords Protection in a Guinea Pig Model. Infect Immun 71: 1929–1937.
[32]
Figdor CG, van Kooyk Y, Adema GJ (2002) C-type lectin receptors on dendritic cells and langerhans cells. Nat Rev Immunol 2: 77–84.
[33]
Ragas A, Roussel L, Puzo G, Rivière M (2007) The Mycobacterium tuberculosis Cell-surface Glycoprotein Apa as a Potential Adhesin to Colonize Target Cells via the Innate Immune System Pulmonary C-type Lectin Surfactant Protein A. Journal of Biological Chemistry 282: 5133–5142.
Wieland CW, Koppel EA, den Dunnen J, Florquin S, McKenzie ANJ, et al. (2007) Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis. Microbes and Infection 9: 134–141.
[36]
Naganathan N, Mahadev B, Challu VK, Rajalakshmi R, Jones B, et al. (1986) Virulence of tubercle bacilli isolated from patients with tuberculosis in Bangalore, India. Tubercle 67: 261–267.
[37]
Challu VK, Chandrashekaran S, Chauhan MM (1998) Haematogenous dissemination of pulmonary isolatesof M. tuberculosis in animal model-a quantitative measurement. Ind J Tuberc 45: 23–27.
[38]
Pal PG, Horwitz MA (1992) Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infection and Immunity 60: 4781–4792.
[39]
VanderVen BC, Harder JD, Crick DC, Belisle JT (2005) Export-Mediated Assembly of Mycobacterial Glycoproteins Parallels Eukaryotic Pathways. Science 309: 941–943.
[40]
Jakowlew S (2006) Transforming growth factor-β in cancer and metastasis. Cancer and Metastasis Reviews 25: 435–457.
[41]
Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL (1996) A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. The Journal of Experimental Medicine 183: 2669–2674.
[42]
Gallucci S, Lolkema M, Matzinger P (1999) Natural adjuvants: Endogenous activators of dendritic cells. Nat Med 5: 1249–1255.
[43]
Pompei L, Jang S, Zamlynny B, Ravikumar S, McBride A, et al. (2007) Disparity in IL-12 Release in Dendritic Cells and Macrophages in Response to Mycobacterium tuberculosis Is Due to Use of Distinct TLRs. The Journal of Immunology 178: 5192–5199.
[44]
Grewal IS, Xu J, Flavell RA (1995) Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378: 617–620.
[45]
Stuber E, Strober W, Neurath M (1996) Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 183 (2 693–698.
[46]
Yang Y, Wilson JM (1996) CD40 Ligand-Dependent T Cell Activation: Requirement of B7-CD28 Signaling Through CD40. Science 273: 1862–1864.
[47]
Rothfuchs AG, Egen JG, Feng CG, Antonelli LRV, Bafica A, et al. (2009) In Situ IL-12/23p40 Production during Mycobacterial Infection Is Sustained by CD11bhigh Dendritic Cells Localized in Tissue Sites Distinct from Those Harboring Bacilli. The Journal of Immunology 182: 6915–6925.
[48]
Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, et al. (2000) Cell Surface Expression and Lipopolysaccharide Signaling Via the Toll-Like Receptor 4-MD-2 Complex on Mouse Peritoneal Macrophages. The Journal of Immunology 164: 3471–3475.
[49]
Reljic R, Di Sano C, Crawford C, Dieli F, Challacombe S, et al. (2005) Time course of mycobacterial infection of dendritic cells in the lungs of intranasally infected mice. Tuberculosis 85: 81–88.
[50]
Lagranderie M, Nahori M-A, Balazuc A-M, Kiefer-Biasizzo H, Lapa E Silva J-R, et al. (2003) Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production. Immunology 108: 352–364.
[51]
Schlesinger LS (1993) Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. The Journal of Immunology 150: 2920–2930.
[52]
Tailleux L, Schwartz O, Herrmann J-L, Pivert E, Jackson M, et al. (2003) DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells. The Journal of Experimental Medicine 197: 121–127.
[53]
Bodnar KA, Serbina NV, Flynn JL (2001) Fate of Mycobacterium tuberculosis within Murine Dendritic Cells. Infect Immun 69: 800–809.
[54]
Tailleux L, Pham-Thi N, Bergeron-Lafaurie A, Herrmann J-L, Charles P, et al. (2005) DC-SIGN Induction in Alveolar Macrophages Defines Privileged Target Host Cells for Mycobacteria in Patients with Tuberculosis. PLoS Med 2: e381.
[55]
Giacomini E, Iona E, Ferroni L, Miettinen M, Fattorini L, et al. (2001) Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response. The Journal of Immunology 166: 7033–7041.
[56]
Nigou J, Zelle-Rieser C, Gilleron M, Thurnher M, Puzo G (2001) Mannosylated Lipoarabinomannans Inhibit IL-12 Production by Human Dendritic Cells: Evidence for a Negative Signal Delivered Through the Mannose Receptor. The Journal of Immunology 166: 7477–7485.
[57]
Koppel EA, Ludwig IS, Hernandez MS, Lowary TL, Gadikota RL, et al. (2004) Identification of the mycobacterial carbohydrate structure that binds the C-type lectins DC-SIGN, L-SIGN and SIGNR1. Immunobiol 209: 117–127.
[58]
Granucci F, Vizzardelli C, Pavelka N, Feau S, Persico M, et al. (2001) Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2: 882–888.
[59]
Granucci F, Zanoni I, Feau S, Ricciardi-Castagnoli P (2003) Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J 22: 2546–2551.
[60]
Khader SA, Partida-Sanchez S, Bell G, Jelley-Gibbs DM, Swain S, et al. (2006) Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. The Journal of Experimental Medicine 203: 1805–1815.
[61]
Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, et al. (1995) Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. The Journal of Immunology 154: 5071–5079.
[62]
Cooper AM, Kipnis A, Turner J, Magram J, Ferrante J, et al. (2002) Mice Lacking Bioactive IL-12 Can Generate Protective, Antigen-Specific Cellular Responses to Mycobacterial Infection Only if the IL-12 p40 Subunit Is Present. The Journal of Immunology 168: 1322–1327.
[63]
Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, et al. (1995) IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. The Journal of Immunology 155: 2515–2524.
[64]
Wakkach A, Fournier N, Brun V, Breittmayer J-P, Cottrez F, et al. (2003) Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In Vivo. Immunity 18: 605–617.
[65]
Hodge JW, Rad AN, Grosenbach DW, Sabzevari H, Yafal AG, et al. (2000) Enhanced Activation of T Cells by Dendritic Cells Engineered to Hyperexpress a Triad of Costimulatory Molecules. Journal of the National Cancer Institute 92: 1228–1239.
[66]
Hodge JW, Sabzevari H, Gómez Yafal A, Gritz L, Lorenz MGO, et al. (1999) A Triad of Costimulatory Molecules Synergize to Amplify T-Cell Activation. Cancer Research 59: 5800–5807.
[67]
Meyer zum Bueschenfelde CO, Unternaehrer J, Mellman I, Bottomly K (2004) Regulated Recruitment of MHC Class II and Costimulatory Molecules to Lipid Rafts in Dendritic Cells. The Journal of Immunology 173: 6119–6124.
[68]
Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, et al. (1994) Activation of human dendritic cells through CD40 cross-linking. The Journal of Experimental Medicine 180: 1263–1272.
[69]
Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, et al. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. The Journal of Experimental Medicine 184: 747–752.
[70]
Iezzi G, Sonderegger I, Ampenberger F, Schmitz N, Marsland BJ, et al. (2009) CD40–CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proceedings of the National Academy of Sciences 106: 876–881.
[71]
Gallegos AM, van Heijst JWJ, Samstein M, Su X, Pamer EG, et al. (2011) A Gamma Interferon Independent Mechanism of CD4 T Cell Mediated Control of M. tuberculosis Infection in vivo. PLoS Pathog 7: e1002052.
[72]
Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MOC (2009) Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. European Journal of Immunology 39: 723–729.
[73]
Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. The Journal of Experimental Medicine 178: 2243–2247.
[74]
Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. The Journal of Experimental Medicine 178: 2249–2254.
[75]
Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235–238.
[76]
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells. Immunity 24: 179–189.
[77]
Singh A, Dey AB, Mohan A, Sharma PK, Mitra DK (2012) Foxp3+ Regulatory T Cells among Tuberculosis Patients: Impact on Prognosis and Restoration of Antigen Specific IFN-γ Producing T Cells. PLoS ONE 7: e44728.
[78]
Fine PEM (1995) Variation in protection by BCG: implications of and for heterologous immunity. The Lancet 346: 1339–1345.
[79]
Wolf AJ, Desvignes L, Linas B, Banaiee N, Tamura T, et al. (2008) Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. The Journal of Experimental Medicine 205: 105–115.
[80]
Blomgran R, Ernst JD (2011) Lung Neutrophils Facilitate Activation of Naive Antigen-Specific CD4+ T Cells during Mycobacterium tuberculosis Infection. The Journal of Immunology 186: 7110–7119.
[81]
Saviola B, Bishai WR (2004) Method to integrate multiple plasmids into the mycobacterial chromosome. Nucleic Acids Research 32: e11.
[82]
Feinberg H, Mitchell DA, Drickamer K, Weis WI (2001) Structural Basis for Selective Recognition of Oligosaccharides by DC-SIGN and DC-SIGNR. Science 294: 2163–2166.
[83]
Stein CM, Zalwango S, Malone LL, Won S, Mayanja-Kizza H, et al. (2008) Genome Scan of M. tuberculosis Infection and Disease in Ugandans. PLoS ONE 3: e4094.
[84]
Kleinnijenhuis J, Quintin J, Preijers F, Joosten LAB, Ifrim DC, et al. (2012) Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proceedings of the National Academy of Sciences 109: 17537–17542.
